Loading...
CTLA-4 correlates with immune and clinical characteristics of glioma
BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...
Na minha lista:
| Udgivet i: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945521/ https://ncbi.nlm.nih.gov/pubmed/31911758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-1085-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|